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Abstract 
There is an increasing demand for synthetic scaffolds with the requisite biocompatibility, 
internal architecture, and mechanical properties for the bone repair and regeneration. In this work, 
scaffolds of a silicate bioactive glass (13-93) were prepared by a freeze extrusion fabrication 
(FEF) method and evaluated in vitro for potential applications in bone repair and regeneration. 
The process parameters for FEF production of scaffolds with the requisite microstructural 
characteristics, as well as the mechanical and cell culture response of the scaffolds were 
evaluated.   After binder burnout and sintering (60 min at 700°C), the scaffolds consisted of a 
dense glass network with interpenetrating pores (porosity ≈ 50%; pore width = 100−500 µm). 
These scaffolds had a compressive strength of 140 ± 70 MPa, which is comparable to the 
strength of human cortical bone and far higher than the strengths of bioactive glass and ceramic 
scaffolds prepared by more conventional methods. The scaffolds also supported the proliferation 
of osteogenic MLO-A5 cells, indicating their biocompatibility. Potential application of these 
scaffolds in the repair and regeneration of load-bearing bones, such as segmental defects in long 
bones, is discussed.  
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1.  Introduction 
There is an increasing demand for synthetic scaffolds with the requisite biocompatibility, 
mechanical properties and internal architecture for the repair and regeneration of tissues and 
organs. An ideal scaffold for bone repair and regeneration should have the following 
characteristics [1]: (1) biocompatible (non-toxic) with the ability to promote cell adhesion, 
proliferation, and differentiation; (2) porous three-dimensional (3D) architecture to allow cell 
proliferation, vascularization, and diffusion of nutrients between the cells seeded within the 
matrix and the surroundings; (3) mechanical properties comparable to the bone to be replaced; (4) 
ability to bond firmly to bone and soft tissue; (5) degradation rate similar to the rate at which 
new bone is formed; (6) processability into the desired anatomical shape.  
Bioactive glass has several attractive properties for application as a scaffold material 
[2,3]. Bioactive glass reacts with the body fluids, forming a surface layer of hydroxyapatite (the 
main mineral constituent of bone) which is responsible for forming a firm bond with hard and 
soft tissues. Bioactive glass is osteoconductive as well as osteoinductive, and has a widely 
recognized ability to support new bone growth. However, porous bioactive glass scaffolds 
fabricated using conventional methods commonly have low strength (<20 MPa) [3,4], so their 
use in the repair and regeneration of load-bearing bones is challenging.  Attempts are currently 
being made to improve the mechanical properties of bioactive glass scaffolds for the repair of 
load-bearing bones [4-6]. These attempts are focused mainly on the control of the pore shape, 
pore size, and pore orientation to improve the strength of the scaffolds.   
Solid freeform fabrication (SFF) can potentially produce scaffolds with customized 
external shape, as well as predefined and reproducible internal architecture (porosity; pore size; 
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and pore distribution). An advantage of the SFF technology is the potential ease of creating 
scaffolds with the anatomical shape and dimensions tailored specifically to individual patients. 
SFF technologies involve building three-dimensional (3D) objects layer by layer. Although there 
are several variants of SFF technology, the general process involves producing a computer-
generated model, which represents the physical prototype to be built, using computer-aided 
design (CAD) software. The model is next converted into a format that is analyzed by a 
computer, which slices the model into cross-sectional layers. The data is then implemented to the 
SFF machine which systematically produces the physical prototype layer by layer. Post-
processing of the formed article is often necessary to remove temporary support structures or 
processing aids, particularly in the case of ceramic and glass particles that are commonly 
difficult to bond directly by most available SFF techniques.   
The most widely researched SFF techniques include fused deposition modeling (FDM) of 
polymeric materials [7,8], fused deposition of ceramics (FDC) [9-11], selective laser sintering 
(SLS) [12,13], 3-D printing [14], stereolithography [15], and robocasting [16]. Freeze extrusion 
fabrication (FEF) has received less attention, but the technique has been used to fabricate dense 
ceramic articles for mechanical engineering applications [17].  FEF is based on a combination of 
techniques taken from fused deposition, freeze casting, and robocasting [18]. In FEF, an aqueous 
mixture with a paste-like consistency is extruded through and orifice to form filaments, which 
are frozen in situ to avoid slumping or distortion of the formed article. The rheology of the paste 
is critical for providing the plastic properties required for avoiding flaws in the formed article. 




In FEF of ceramic or glass, particles are commonly mixed with a polymeric binder phase 
to provide the required plastic properties for extrusion. FEF of these materials involve key post-
processing steps. Following freeze drying to remove the frozen liquid, a binder removal step is 
necessary prior to a sintering step in which the particles are thermally bonded to form a strong 
network. Ideally, the binder phase used to impart the plasticity to the extrudate must be removed 
completely (typically by thermal decomposition) prior to the onset of the sintering step to avoid 
the presence of impurity phases in the final article. In the sintering step, the article is heated to a 
sufficiently high temperature to cause matter transport in order to bond the particles into a dense 
strong network. In the case of ceramics, the sintering temperature is typically 0.5−0.9 of the 
melting temperature, whereas the sintering temperature is typically between the glass transition 
temperature and the melting temperature for glass.    
In the last decade, SFF methods have been widely applied to the production implants and 
scaffolds for biomedical applications. The biomaterials used in these studies have been mainly 
biodegradable polymers such as poly(glycolic acid), poly(lactic acid) and their copolymers, bio-
inert metals such as titanium, and bioactive ceramics such as hydroxyapatite [19-28]. There is 
growing interest in the production of bioactive ceramics and bioactive glass scaffolds for 
potential bone repair applications because their attractive properties.  
The objective of this work was to evaluate the feasibility of forming bioactive glass 
scaffolds using an FEF technique. The development of extrudable paste with optimized rheology 
and the process parameters for the production of scaffolds with pre-determined internal 
architecture were studied. A silicate bioactive glass designated 13-93 was used in this work 
because of our previous experience with forming scaffolds of this glass using more conventional 
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techniques. Products of 13-93 bioactive glass are also approved for in vivo use in the United 
States, Europe, and elsewhere [29].  
 
2.  Experimental Procedures 
2.1.  Preparation of starting materials and extrudable paste 
The bioactive glass used in this work is designated 13-93, with the composition (wt%): 
53.0 SiO2, 6.0 Na2O; 12.0 K2O; 6.0 MgO, 20.0 CaO; 4.0 P2O5. Coarse particles of the glass were 
kindly provided by Mo-Sci Corp., Rolla, Missouri. The as-received glass particles were ground 
to a size finer than ∼3 µm, using a combination of two methods. Particles of size smaller than 45 
µm were first obtained by grinding the as-received particles in a steel shatterbox (SPEX 
SamplePrep LLC, Metuchen, NJ) and sieving the particles through a 325 mesh sieve. 
Approximately 100 g of these particles were then dispersed in deionizedwater and ground for 1 h 
in an attrition mill (Model 01-HD, Union Process, Akron, OH) using ZrO2 grinding media.  After 
evaporation of the water from the attrition-milled slurry using a hot plate, the particles were dried 
for 24 h in oven at 65°C. The dried, agglomerated powder was ground in an agate mortar and 
pestle, and sieved through a 325 mesh sieve.   
An extrudable paste for use in the FEF process was prepared as follows. First, an 
aqueous-based slurry with the composition given in Table I, consisting of glass particles, 
deionized water, and polymeric additives, was formed into a homogeneous mixture by ball 
milling for 24 h using Al2O3 milling media. These polymeric additives were selected because 
they were used previously in the fabrication of Al2O3 articles by the FEF method [18]. Second, 
the ball-milled slurry was heated under a controlled temperature/time schedule (70 min at 65°C) 
to evaporate some of the water, and to control the viscosity of the paste. Pastes with different 
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viscosities were tested in the FEF equipment to determine whether they were extrudable, and the 
system with the optimum viscosity for extrusion was chosen by a trial-and-error method. 
    
Table I.  Composition of starting slurry used in the preparation of the extrudable paste for FEF. 
 
Component Concentration (vol%) Function Manufacturer 
13-93 glass particles 40.00 Solid phase Mo-Sci Corp., Rolla, MO 
EasySperse 0.50 Dispersant ISP Technologies, Inc., Wayne, NJ 
Surfnol 0.50 Defoamer Air Products & Chemicals, Inc., Allentown, PA 
Glycerol 1.00 WCCA* Alfa Aesar, Ward Hill, MA 
PEG 400 1.00 Lubricant Alfa Aesar, Ward Hill, MA  
Aquazol 5 4.00 Binder ISP Technologies, Inc., Wayne, NJ 
Deionized water 53.00 Solvent — 
   *WCCA: Water crystallization control agent 
2.2  Freeze extrusion fabrication of bioactive glass scaffold 
Figure 1 shows images of the main components of the FEF equipment used in this work. 
The paste to be extruded is loaded into a heated reservoir housed in a computer-controlled gantry 
that allows programmable movement in three dimensions. A nozzle attached to the reservoir 
determines the diameter of the extrudate which is deposited on a fixed platform cooled to the 
required temperature using liquid nitrogen. The system is contained within a cooled chamber.  
In the present work, the fabrication environment temperature was  −20°C. The paste was 
extruded layer by layer, with each layer deposited at 90° relative to the preceding layer. Based on 
the rheology of the paste, the software in the FEF machine was adjusted to control the extrusion 
force and rate of deposition. A nozzle diameter of 580 µm was used in these experiments, and 




Figure 1. Images showing the main components of the freeze extrusion fabrication equipment 
used in the present work. 
 
   
2.3.  Post processing of as-formed FEF construct 
The decomposition kinetics of the polymeric binder (without glass particles) were 
followed using thermogravimetric analysis (STA409, NETZSCH). Based on these kinetic data, a 
temperature−time schedule was developed for the removal of the polymeric additives from the 
as-formed FEF construct. The objective was to completely remove the binder by thermal 
decomposition prior to sintering of the glass particles. Incomplete removal of the binder prior to 
sintering resulted in scaffolds with a black color, due to residual carbon entrapped in the glass. A 
schedule lasting 5 days, consisting of a slow heating rate (3−5°C/h) and several isothermal 
holding stages, resulted in complete removal of the binder. Following the binder removal 
schedule, the construct was sintered in air for 1 h at 700°C (heating rate = 5°C/min) to densify 
the glass phase. 
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2.4.  Structural and mechanical evaluation of 13-93 bioactive glass scaffolds 
Following the sintering step, bioactive glass scaffolds were ground to form a powder 
(<45 µm) and analyzed using X-ray diffraction, XRD (Model D/mas 2550 v; Rigaku, The 
Woodlands, TX). The analysis was performed using Cu Kα radiation (λ = 0.15406 nm) at a 
scanning rate of 0.01° 2θ/min in the range 3−90° 2θ. The microstructure of the scaffold and the 
glass phase was examined using conventional methods in an optical microscope and a scanning 
electron microscope, SEM (S-4700; Hitachi, Japan).  
The mechanical response of the fabricated scaffolds in compression was measured at a 
crosshead speed of 0.2 mm/min in an Instron machine (Model 4205; Instron, Norwood, MA). Six 
cube-shaped samples (5 mm in length), surface ground using a diamond coated wheel and 
sectioned using a diamond-coated blade from the fabricated scaffolds, were tested. The 
compression force was applied along the thickness direction of the scaffold.   
 
2.5.  Cell culture 
The ability of the fabricated scaffolds to support the proliferation of MLO-A5 cells, an 
established murine osteogenic cell line, was used to confirm their biocompatibility. The MLO-
A5 cells were kindly provided by Professor Lynda F. Bonewald, University of Missouri-Kansas 
City. After they were washed twice with water and dried, cube-shaped scaffolds (5 mm in 
length), similar to those used the mechanical tests described above, were sterilized by heating for 
2 h at 500°C, seeded with 50,000 MLO-A5 cells suspended in 100 µl of complete medium and 
incubated for 4 h to permit cell attachment. The cell-seeded scaffolds were then transferred to a 
24-well plate containing 2 ml of complete medium per well. All cell cultures were maintained at 
37 ºC in a humidified atmosphere of 5% CO2, with the medium changed every 2 days.  
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To visualize the metabolically active cells on and within the scaffolds, each cell-seeded 
scaffold was placed in 0.2 ml serum-free medium containing 0.1 mg of the tetrazolium salt MTT 
for the last 4 h of incubation. After incubation, the scaffolds were briefly rinsed in PBS, blotted, 
and allowed to dry. Images of the scaffolds were obtained using a stereomicroscope fitted with a 
digital camera to qualitatively assess the distribution of insoluble purple formazan, a product of 
mitochondrial reduction of MTT by viable cells. 
 
3.  Results and Discussion 
3.1.  Structural characteristics of bioactive glass scaffolds 
Figure 2 shows optical images of 13-93 bioactive glass constructs, as-formed by the FEF 
technique (Figure 2a), and after sintering at 700°C (Figure 2b). The as–formed construct 
(approximately 36 mm × 30 mm × 6 mm thick) was obtained by extrusion of the paste thorough 
an orifice of diameter 580 µm. The diameter of the deposited filaments (∼600 µm) was slightly 
larger than the diameter of the orifice due to expansion of the plastic paste upon extrusion. As 
shown, the width of the pores in the plane of the deposition was ∼500 µm and the porosity of the 
as-formed FEF construct was ~75% (including the porosity of the glass filaments).  
There was no measurable shrinkage of the FEF scaffold during the freeze drying step, 
and the shrinkage during the binder burnout step was small (linear shrinkage <3%). However, the 
construct shrank considerably during the sintering step, as a result of the densification of the 
network of fine glass particles. The linear shrinkage was ~28% in the plane of deposition, and 
∼20% in the thickness direction of the scaffold. The sintered scaffolds consisted of glass 
filaments with a thickness of ∼300 µm, porosity of ~50%, and pore width (in the plane of the 




Figure 2.  Optical images showing a bioactive glass construct (a) as-formed by the FEF 
technique, and (b) after binder burnout and sintering. 
 
Table II. Structural characteristics of bioactive glass scaffolds as-formed by FEF and after 
sintering at 700°C. 
Parameter FEF scaffold Sintered scaffold 
Filament diameter (µm) 600 300 
Porosity (%) 75* 50 
Pore width (µm) 500 300 
*Porosity including the porosity in the filaments before sintering  
As Figure 2 shows, the FEF construct retained its shape and architecture during the post- 
processing steps (freeze drying, binder burnout; sintering). SEM images of fractured cross 
sections (Figure 3) showed that sintering resulted in almost complete densification of the glass 
phase, and the glass network contained only a few fine, isolated pores. Furthermore, there was 
good bonding between the adjacent layers of the sintered scaffold. These structural 
characteristics are desirable for enhancing the overall strength of the sintered scaffold. The 
ability to achieve nearly full density presumably resulted from the fine particle size of the 
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starting glass particles (<3 µm), the homogeneous mixing of the particles and binder phase in the 
paste used in the extrusion, and high packing density of the glass particles in the paste.  
Figure 3a shows that the pore width (100−150 µm) in the thickness direction of the 
sintered scaffold was smaller than that in deposition plane (~300 µm). This smaller pore width in 
the thickness direction resulted presumably from deformation due to gravitational effects during 
the FEF step and particularly during the sintering step. In sintering, the reduction in the viscosity 
of the glass, necessary to achieve viscous flow densification of the glass phase and bonding 
between adjacent layers of the scaffold, also enhanced deformation of the glass by creep under 
the force of gravity.  
 
Figure 3.  SEM images of the fractured cross section of a sintered bioactive glass scaffold 
showing (a) good bonding between adjacent layers of the scaffold, and (b) almost full 
densification of the glass phase. (The section was along the thickness direction of the scaffold.) 
 
X-ray analysis of the sintered scaffolds did not show any diffraction peaks (Figure 4). 
Instead, the XRD pattern showed a broad band (centered at ∼30° 2θ) characteristic of a glass. 
The ability to avoid crystallization of the bioactive glass during the scaffold fabrication process 
is beneficial for achieving high density of the glass network in the scaffold (and, hence for 
achieving high strength) and for maintaining the bioactive potential of the glass. Crystallization 
during sintering leads to a glass−ceramic material which is often difficult to densify. Furthermore, 
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while the glass−ceramic still retains the ability to form a hydroxyapatite surface layer, the rate of 
formation of the hydroxyapatite layer is markedly reduced.  
 
Figure 4. X-ray diffraction pattern of sintered bioactive glass scaffold, showing that the glass 
remained amorphous after the sintering step. 
 
3.2.  Mechanical response of sintered bioactive glass scaffolds 
 Figure 5a shows cube-shaped samples that were used in tests to measure the mechanical 
response of the sintered scaffolds in compression. The scaffolds showed a brittle response, 
typical of dense ceramics and glass (Figure 5b). The applied compressive stress increased almost 
linearly with the deformation until the sample failed in a catastrophic manner into several pieces. 
For the 6 samples tested, the compressive strength of the scaffold was 140 ± 70 MPa. This 
average strength is in the range of values reported for human cortical bone (120−180 MPa). The 
large standard deviation in the compressive strength may result from sample non-uniformity due 
to the small size of the samples tested and from macroscopic flaws arising from the FEF process. 
Since the linear dimension of the samples was 5 mm, variable in the sample uniformity can have 
a marked effect on the mechanical properties. The elastic modulus of the samples, determined 
from the slope of the stress vs. strain data, was 5−6 GPa, which is lower than the elastic modulus 
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of cortical bone (10−20 GPa).   
 
 
Figure 5. (a) Cube-shaped samples (5 mm in length) used in mechanical testing; (b) mechanical 
response (applied stress vs. deformation) of a sample in compression.  
 
 Table III shows a comparison of the compressive strengths of biodegradable polymer, 
bioactive glass, and hydroxyapatite scaffolds prepared by various methods [30]. The values 
shown in Table III are not meant to be exhaustive. Instead, they show the results of selected 
studies for various biomaterials and scaffold fabrication techniques. Although the compressive 
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strength in the present study showed a large standard deviation, the lowest strength (60 MPa) is 
still far higher than the strengths of biodegradable polymer scaffolds, as well as bioactive glass 
and hydroxyapatite scaffolds prepared by more conventional methods.  
  
Table III. Summary of pore characteristics and compressive strength of scaffolds fabricated by a 








Freeze casting HA 47-52 5-30 12-18 
 HA 50-65 80-110 7.5-20 
 HA 40-65 20 40-145 
TIPS PLLA/HA(50:50) 90 50-200 0.4 
 PLGA 93-94 50-60 0.38-0.58 
 PDLLA/Bioglass® 93.5-94  0.07-0.08 
 PLGA 90-96 114-137 0.2-0.9 
 HA/Collagen 95 200-500 0.03 
Polymer sponge HA 86 420-560 0.21 
 Glass reinforced HA 85-97.5 420-560 0.01-0.175 
 HA 70-77 200-400 0.55-5 
 45S5 Bioglass® 89-92 510-720 0.27-0.42 
 Ca2MgSi2O7 63-90 300-500 0.53-1.13 
Gel casting HA 76-80 20-1000 4.4-7.4 
 HA 72-90 17-122 1.6-5.8 
SFF PCL 61 360 × 430 × 620 3.1 
 HA 35 334 × 469 30 
 HA 41 250-350 34 
Slip casting 13-93 glass 40-45 100-300 21-23 
 HA 85 200-500 1.09-1.76 
Gas foaming PLGA 85-96 193-439 0.16-0.29 
Fiber compacting HA 13-33 500-500 6-13 
 
3.3  Biocompatibility of sintered bioactive glass scaffolds 
Photographic images of scaffolds seeded with MLO-5A cells, cultured for 2, 4, and 6 
days, and treated with MTT during the last 4 h of incubation are shown in Figure 6. The purple 
pigment visible on the scaffold is an indication of viable cells, and is the result of mitochondrial 
reduction of MTT to an insoluble formazan product. The increase in the intensity of the purple 




Figure 6. Optical images showing cell-seeded bioactive glass scaffolds treated with MTT after 
culture intervals of (a) 2 days; (b) 4 days, and (c) 6 days. The increase in intensity of the purple 
color (arrow) indicates the ability of the scaffolds to support cell proliferation. 
 
 The present work shows promising results for using the FEF technique in the fabrication 
of bioactive glass scaffolds for the repair and regeneration of load bearing bones. In addition to 
the benefit of other SFF methods in producing articles with predesigned external shape and 
internal architecture, the FEF was shown to produce porous 3D scaffolds with an almost fully 
dense glass network, which resulted in a compressive strength comparable to that of cortical 
bone. 
   
4.  Conclusions 
The present results showed the feasibility of a freeze extrusion fabrication (FEF) 
technique for creating bioactive glass scaffolds with the requisite pore architecture and 
mechanical strength for potential application in the repair and regeneration of load-bearing bones. 
An extrudable paste was developed for the production of scaffolds with uniform shape and 
internal architecture. The scaffolds retained their external shape and internal architecture during 
the FEF process, as well as during the post-processing steps (freeze drying; binder removal; 
sintering). Sintered scaffolds of 13-93 glass with a porosity of ∼50%, and interconnect pores of 
size 300 × 300 × 100−150 µm, had a compressive strength of 140 ± 70 MPa, comparable to the 
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strength of human cortical bone. These sintered scaffolds showed a brittle mechanical response 
in which the stress increased linearly with deformation until catastrophic failure. The scaffolds 
remained amorphous after sintering, and supported the proliferation of osteogenic MLO-A5 cells, 
showing their biocompatibility.  
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